Literature DB >> 14102771

RESTENOSIS OF MITRAL VALVE: A STUDY OF 100 CASES TREATED BY OPERATION.

J R BELCHER, R L GUPTA.   

Abstract

Keywords:  HEART SURGERY; MIDDLE AGE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STATISTICS

Mesh:

Year:  1964        PMID: 14102771      PMCID: PMC1814032          DOI: 10.1136/bmj.1.5387.871

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Multiple calcific embolism following mtral valvotomy.

Authors:  M J ADAMS
Journal:  Br Heart J       Date:  1961-05

2.  Recurrent stenosis of the mitral valve.

Authors:  J R DE JESUS; G M BRENEMAN; J W KEYES
Journal:  Circulation       Date:  1962-04       Impact factor: 29.690

3.  Recurrent mitral stenosis. An analysis of findings in 32 cases submitted to reoperation

Authors:  K FRASER; I F KERR
Journal:  Br Med J       Date:  1962-08-18

4.  A clinical study of 1,000 consecutive cases of mitral stenosis two to nine years after mitral valvuloplasty.

Authors:  L B ELLIS; D E HARKEN; H BLACK
Journal:  Circulation       Date:  1959-06       Impact factor: 29.690

5.  Failed mitral valvotomy.

Authors:  J K ROSS
Journal:  Thorax       Date:  1959-12       Impact factor: 9.139

6.  The influence of mitral regurgitation on the results of mitral valvotomy.

Authors:  J R BELCHER
Journal:  Lancet       Date:  1956-07-07       Impact factor: 79.321

7.  Deterioration after mitral valvotomy.

Authors:  C P LOWTHER; R W TURNER
Journal:  Br Med J       Date:  1962-04-14

8.  Reoperation for mitral stenosis.

Authors:  A LOGAN; C P LOWTHER; R W TURNER
Journal:  Lancet       Date:  1962-03-03       Impact factor: 79.321

  8 in total
  2 in total

1.  Mitral valvotomy in patients aged 50 years and over.

Authors:  J M Reid; R S Barclay; J G Stevenson; T M Welsh; N McSwan
Journal:  Br Med J       Date:  1966-10-29

2.  Mitral valvotomy and embolism.

Authors:  G Bakoulas; K Mullard
Journal:  Thorax       Date:  1966-01       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.